Metraipolis › archive › dc_68cf252d9d2c

Dual-Target Insight into Drug Discovery from Natural Products as Modulators of GLP-1 and the TXNIP-Thioredoxin Antioxidant System in Metabolic Syndrome — Europe PMC PMID:41300521

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41300521
DOI
10.3390/antiox14111364
License (as archived)
solo-consultazione
Archived
2026-11-08T12:32:05.478Z
SHA-256 of the archived text
640b19e667a11932c36e2c405a9b3762983cf1ee502f3f5a000401836ff3b15c
Stable URL of this page
https://metraipolis.com/documento/dc_68cf252d9d2c

How to cite

Dual-Target Insight into Drug Discovery from Natural Products as Modulators of GLP-1 and the TXNIP-Thioredoxin Antioxidant System in Metabolic Syndrome — Europe PMC PMID:41300521 — Europe PMC (en), https://europepmc.org/article/MED/41300521 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68cf252d9d2c (Metraipolis archive dc_68cf252d9d2c, sha256 640b19e667a11932c36e2c405a9b3762983cf1ee502f3f5a000401836ff3b15c)
BibTeX
@misc{dc68cf252d9d2c,
  title = {Dual-Target Insight into Drug Discovery from Natural Products as Modulators of GLP-1 and the TXNIP-Thioredoxin Antioxidant System in Metabolic Syndrome — Europe PMC PMID:41300521},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41300521},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68cf252d9d2c; sha256 640b19e667a11932c36e2c405a9b3762983cf1ee502f3f5a000401836ff3b15c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41300521. Agents can read the archived copy with the MCP tool read_document.